"So from this we may want to keep a keen eye on ACAD announcements"
I have been doing that for the past few weeks. I found out about the P3 result via ACAD (before the NEU ann) and expect similar again.
Pointy end has finally arrived - irrationally nervous but so much hangs on this result - said it before, but will shout it again - GO NEUREN! (and ACAD)
Ann: Rett Syndrome NDA accepted for Priority Review by FDA, page-95
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.06 |
Change
-0.290(2.35%) |
Mkt cap ! $1.545B | |||
| Open | High | Low | Value | Volume |
| $12.20 | $12.20 | $12.04 | $669.6K | 55.32K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 182 | $12.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.08 | 974 | 12 |
View Market Depth
| Last trade - 11.13am 01/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |